Sanofi Winthrop Industrie
PolandAll drugs from this manufacturer
-
The vaccine helps protect children from 6 weeks of age against diphtheria, tetanus, pertussis, poliomyelitis, and invasive infections caused by Haemophilus influenzae type b (such as meningitis or septicaemia).
Dosage form: powder and suspension for preparation of injection suspension
Active substance Dosage inactivated poliovirus type 1 40 units of antigen D inactivated poliovirus type 2 8 units of antigen D inactivated poliovirus type 3 32 units of antigen D haemophilus influenzae type b conjugated polysaccharide-tetanus toxoid conjugate 10 mcg diphtheria toxoid not less than 30 IU tetanus toxoid not less than 40 IU bordetella pertussis antigens 25 mcg + 25 mcg ATC: J07CA02
-
This vaccine provides protection against yellow fever, a severe infectious disease transmitted by the bites of infected mosquitoes. It is used in individuals traveling to countries where the disease is present, in persons requiring an international certificate of vaccination, and in workers exposed to infectious material.
Dosage form: powder and solvent for preparation of suspension for injection
Active substance Dosage live attenuated yellow fever virus strain 17d-204 not less than 1000 LD50 ATC: J07BL01